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Abstract Spectroscopic (1H NMR and UV–vis) and electro-
chemical (CV) techniques have been applied to study the
reaction of Gly-Met dipeptide with [Au(en)Cl2]
+ complex
having bidentate coordinated ethylenediamine (en) ligand.
The final product in the investigated reaction was Gly-Met
sulfoxide, formed by the oxidation of methionine residue with
[Au(en)Cl2]
+. The formation of Gly-Met sulfoxide proceeds
through two steps including the monodentate coordination of
thioether sulfur atom of methionine residue and release of en
ligand fromAu(III). In order to investigate the influence of the
pH and Cl− concentration on this redox process, the reaction
was performed in solution of KCl with the concentration
varying from 0.01 to 0.50 M and in the pH range 2.00–5.00.
The obtained kinetic data showed that oxidation ofmethionine
residue in Gly-Met was 200 times slower in comparison to the
same process with previously investigated [AuCl4]
− complex.
Difference in the oxidation rate of Gly-Met between these two
complexes was attributed to the presence of chelated
ethylenediamine ligand in [Au(en)Cl2]
+. The finding that the
oxidation of sulfur-containing peptides and proteins can be
inhibited by structural modifications of gold(III) complexes
introducing polydentate nitrogen-containing ligands can con-
tribute in designing new gold(III) complexes with lower toxic
side effects.
Keywords Methionine-containing peptide .
Gold(III)-induced oxidation . ProtonNMR .UV–vis . Cyclic
voltammetry
Introduction
Gold and its complexes have been playing an important role in
medicine since ancient times [1]. Some gold(I) complexes,
such as auranofin and aurothiomalate, have been used very
successfully in the treatment of rheumatoid arthritis [2], while
gold(III) complexes have gained considerable attention as
potential antitumor agents [3]. During the recent years, a large
number of gold(III) complexes, in which the reduction poten-
tial of the Au(III) was lowered by the use of polydentate
ligands, have been reported to be appreciably stable under
physiologically relevant conditions and to manifest relevant
cytotoxic activity against different human tumor cell lines
[4–16]. The possible involvement of gold(III) complexes in
cancer treatment initiated an interest in the area of gold(III)
interactions with different biologically important ligands, such
as amino acids and peptides [17]. It was shown that the amino
acid L-histidine and L-histidine-containing peptides with N3
anchoring site of the imidazole ring are good chelating ligands
for Au(III) ion [18–20]. Moreover, the formed gold(III) com-
plexes with L-histidine-containing peptides are very stable
under physiologically relevant conditions with promising cy-
totoxic properties toward different human tumor cell lines
[21]. On the other hand, the reactions of Au(III) with sulfur-
containing amino acids and peptides primarily proceed
through the reduction of Au(III) ion and oxidation of sulfur
side chain [22–32]. Thus, Au(III) rapidly oxidizes the thiol-
containing amino acid L-cysteine to its disulfide cystine and,
afterwards, cleaves the disulfide bond of cystine to give
cysteic acid, thereby being reduced to Au(I) and Au(0)
[22–26]. Furthermore, Au(III) is capable to oxidize methio-
nine and methionine-containing peptides to the corresponding
sulfoxides [27–32]. These interactions are thought to be re-
sponsible for the toxic side effects of gold-based drugs.
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Recent studies showed that the reactions of [AuCl4]
− with
Gly-Met dipeptide and its N-acetyl derivative, Ac-Gly-Met,
proceed in two steps [31]. The first step is a very fast coordination
of Au(III) ion to the thioether sulfur with formation of an
intermediate gold(III)–peptide complex, [AuCl3(R-Gly-Met-S)]
(R = H and Ac). This intermediate product further reacts with an
additional methionine residue to generate corresponding
chlorosulfonium cation, which readily undergoes hydrolysis to
give the R-Gly-Met sulfoxide as the final product of the redox
process. Moreover, the structure of the corresponding sulfoxide
as the final product of gold(III)-induced oxidation of methionine-
containing peptides was confirmed by X-ray crystallography
[32]. In a continuation of our previous investigations [31, 32],
in the present study an attempt was made to gain insight into
course of the reactions of gold(III) complexes containing
polydentate ligands with methionine-containing peptides. For
this purpose, 1HNMR spectroscopy, UV–vis spectrophotometry,
and cyclic voltammetry (CV) have been used to study the
reaction of [Au(en)Cl2]
+ complex (en is bidentate coordinated
ethylenediamine) with Gly-Met dipeptide.
Experimental
Reagents
Distilled water was demineralized and purified to a resistance
of greater than 10 MΩ cm−1. The compounds D2O, DCl,
KOD, H[AuCl4]·3H2O, and ethylenediamine (en) were pur-
chased from Sigma-Aldrich Chemical Co. The dipeptide
glycyl-D ,L -methionine (Gly-Met) was obtained from
Bachem A.G. Hydrochloric acid, potassium chloride, and
absolute ethanol were obtained from Zorka Pharma. All the
employed chemicals were of analytical reagent grade.
Synthesis of the [Au(en)Cl2]Cl·2H2O complex
The [Au(en)Cl2]Cl·2H2O complex was synthesized by modifi-
cation of the previously described methods [33, 34]. To the
solution of 0.5 mmol of H[AuCl4]·3H2O (196.9 mg) in absolute
ethanol (10.0 mL), an equimolar amount of en ligand (33.8 μL,
99 %, ρ=0.898 g/mL) was added. An orange precipitate, which
was formed immediately after addition of en, redissolved after
30 min. The resulting pale yellow solution was stirred in the
dark for 2 h at room temperature, and then left standing to slowly
evaporate. Pale yellow crystals of the [Au(en)Cl2]Cl·2H2O com-
plex formed after 2 days were removed by filtration and air-
dried. The yield was 54 % (107.9 mg). The purity of the
complex was checked by elemental microanalysis and NMR
(1H and 13C) spectroscopy. Analytical calculations for
[Au(en)Cl2]Cl·2H2O = C2H12AuCl3N2O2 (FW 399.45): C,
6.01; H, 3.03; N, 7.01. Found: C, 6.15; H, 2.96; N, 6.87 %.
1HNMR (D2O, 200MHz); δ 3.27 (s , enCH2).
13C NMR (D2O,
50 MHz): δ 53.68 (enCH2). All these data were in accordance
with those previously reported for the [Au(en)Cl2]Cl·2H2O
complex [33, 34].
Measurements
Elemental microanalysis of the gold(III) complex
Elemental microanalysis for carbon, hydrogen, and nitrogen
of the synthesized gold(III) complex was performed by the
Microanalytical Laboratory, Faculty of Chemistry, University
of Belgrade.
1H NMR spectroscopy
All 1H NMR spectra were recorded on a Varian Gemini 2000
spectrometer (200 MHz) using 5-mm NMR tubes. Sodium
trimethylsilylpropane-3-sulfonate (TSP, δ 0.00 ppm) was used
as an internal reference. The NMR spectra were processed
using the Varian VNMR software (version 6.1, revision C).
The chemical shifts are reported in parts per million (ppm).
Fresh solutions of the gold(III) complex and Gly-Met
dipeptide were prepared separately in D2O as solvent at an
initial concentration of 20 mM and then mixed in a NMR tube
in 1:1 molar ratio. All reactions were performed in the pH
range 2.00–5.00 and at room temperature (25 °C). In order to
investigate the effect of the chloride concentration, the reac-
tions were performed in the presence of potassium chloride,
with Cl− concentration varying from 0.01 to 0.50 M. All rate
constants were obtained from the 1H NMR data recorded at
appropriate time intervals. The release of bidentate coordinat-
ed en ligand from the Au(III) ion was fitted to a first-order
process [35] by plotting ln(a0/at) against t (a0 is the concen-
tration of the intermediate Au(III)-bound methionine complex
and at is the concentration of this complex at time t). The
concentration of the gold(III) complex was determined by
integration of the singlets at 3.27 and 3.38 ppm, corresponding
to the CH2 methylene protons of coordinated and free
ethylenediamine, respectively.
In order to compare the rate constant of the reaction be-
tween Gly-Met and [Au(en)Cl2]
+ with that previously report-
ed for the reaction between this dipeptide and [AuCl4]ˉ [31],
herein the [Au(en)Cl2]
+ and Gly-Met were dissolved in
0.01 M DCl at pH 2.00 and 25 °C, and then reacted in 1:1
molar ratio. The value of the rate constant was determined
from the 1H NMR measurements, when the data from the
early part of the reaction were fitted to a second-order process
[35] by plotting x/a0(a0−x) against t (where a0 is the initial
concentration of the Gly-Met dipeptide and x is the concen-
tration of the sulfoxide at time t ). The concentration of Gly-
Met sulfoxide was determined by integration of the singlet for
the –SCH3 methyl protons of Gly-Met sulfoxide at 2.71 ppm.
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Voltammetric measurements by cyclic voltammetry
Cyclic voltammetric measurements were performed with an
Autolab potentiostat (PGSTAT 302N). The working electrode
for the cyclic voltammetric measurements was glassy carbon
(GC) with 3 mm inner and 9 mm outer diameter of the PTFE
sleeve. Prior to use, the GC electrode was wet-polished on an
Alpha A polishing cloth (Mark V Lab) with small particles of
alumina (0.05 μm diameter). The electrode was washed twice
with doubly distilled water and then with the background elec-
trolyte solution. The washed electrode was placed into a
voltammetric cell with supporting electrolyte solution. The ref-
erence electrode was a saturated calomel electrode type 401
(Radiometer, Copenhagen) and the counter electrode was a
platinum wire.
The supporting electrolyte used to perform the cyclic
voltammetric experiments was 0.50 M KCl at pH 2.00. The
concentration of the gold(III) complex in the final solution was
1.00·10−3 M. The conditions were as following: Ebegin=−0.5 V,
Eend=1.5 V, and Estep=0.003 Vat a scan rate of 0.070 V s
−1. All
experiments were repeated at least three times. The data were
collected and analyzed using the Origin 8 program.
UV–vis spectrophotometry
TheUV–vis spectra were recorded on a PerkinElmer Lambda 35
double-beam spectrophotometer equipped with thermostated
1.00-cm quartz Suprasil cells. Stock solutions of the gold(III)
complex and Gly-Met were prepared directly before use in 0.01–
0.50 M KCl at 2.00≤pH≤5.00 and 25 °C. The UV–vis spectra
were recorded in the first 1 h after mixing of [Au(en)Cl2]
+ and
Gly-Met in 1:1, 1:2, and 1:3 molar ratios, respectively, as well as
after 3, 24, and 48 h over thewavelength range 200–500 nm. The
concentration of the gold(III) complex in the final solutions was
in the range 1.67·10−4–5.00·10−4 M. Data were collected and
analyzed using Origin 8 and Microsoft Office Excel 2007
programs.
pH measurements
All pH measurements were performed at room temperature
(25 °C). The pH meter (Iskra MA 5704) was calibrated with a
Fischer certified buffer solution of pH 4.00. All pH* values
measured in D2O solutions were recalculated into pH valid for
H2O by using the previously reported equation: pH=0.929pH*+
0.42 [36].
Results and discussion
In general, gold(III) complexes are relatively unstable and easily
reducible to gold(I) species and metallic gold, due to their high
reduction potential and fast rate of hydrolysis [2]. Stability of the
Au(III) ion can be achieved by the appropriate choice of the
ligands, in most cases containing nitrogen donor atoms [4–16].
Herein, a gold(III) complex containing polydentate ligand,
namely [Au(en)Cl2]
+, has been synthesized and utilized in order
to verify whether the introduction of a chelate ligand enhances
the stability of gold(III) complexes in their reactions with
methionine-containing peptides. The solution behavior of
[Au(en)Cl2]
+ complex and course of its reaction with Gly-Met
dipeptide have been investigated in the presence of KCl with the
concentration varying from 0.01 to 0.50 M at 2.00≤pH≤5.00
and 25 °C by 1H NMR, UV–vis, and CV techniques. This
investigation has not been performed at pH>5.00, due to the
fact that [Au(en)Cl2]
+ complex, under these conditions, forms a
brown precipitate insoluble in water at room temperature [33].
The reaction of [Au(en)Cl2]
+ with Gly-Met
In the reaction of [Au(en)Cl2]
+ complex with an equimolar
amount of Gly-Met dipeptide, under the abovementioned
experimental conditions, Gly-Met sulfoxide was observed as
the final product (Fig. 1 and Table 1). This product resulted
from the oxidation of methionine residue in the dipeptide
induced by Au(III) and its formation can be successfully
followed by 1H NMR spectroscopy (Fig. 1). The singlet at
2.71 ppm was assigned to the –SCH3 methyl protons of Gly-
Met sulfoxide, which is in agreement with that previously
reported for [H+Gly-Met sulfoxide][AuCl4] characterized by
1H NMR spectroscopy and X-ray crystallography [31, 32].
The formation of Gly-Met sulfoxide in the investigated
reaction proceeds through two consequent steps. The first step
of the redox process is the coordination of the sulfur atom of
methionine residue of Gly-Met dipeptide to the Au(III) ion.
This was noticed in the 1H NMR spectrum by the appearance
of a new singlet due to the –SCH3 methyl protons of Au(III)-
bound methionine species, [Au(en)Cl(Gly-Met-S )]2+. The
chemical shift of this singlet is in the region between chemical
shifts of –SCH3 protons of the free dipeptide (2.11 ppm) and
these protons of Gly-Met sulfoxide (2.71 ppm). This singlet
was shifted downfield during time depending on the concen-
tration of the oxidized product. As a consequence of the
formation of the intermediate Au(III)-bound methionine spe-
cies, a release of chelated ethylenediamine ligand fromAu(III)
was observed. The detachment of en ligand from the Au(III)
can be easily detected in the 1H NMR spectrum by the
simultaneous decline of the resonance at 3.27 ppm due to
the methylene protons of bidentate coordinated en ligand,
and the growth of the resonance at 3.38 ppm corresponding
to these protons for free en (Table 1). Upon addition of
ethylenediamine to the reaction mixture, the resonance at
3.38 was enhanced. The release of en ligand from Au(III)
ion can be attributed to the trans influence of the coordinated
thioether sulfur atom. In order to confirm that release of en
ligand occurred only in the presence of Gly-Met dipeptide, the
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behavior of [Au(en)Cl2]
+ complex in aqueous solution of KCl
(0.01–0.50 M) in the pH range 2.00–5.00 has been investigat-
ed. Under these experimental conditions, no release of
ethylenediamine ligand from Au(III) complex was observed
during 48 h.
Furthermore, the formation of the intermediate Au(III)-
methionine species was confirmed by CV measurements. As
a result of the coordination of thioether sulfur atom to Au(III),
the characteristic cathodic peak I at 0.15 V, corresponding to
the reduction of [Au(en)Cl2]
+ complex ([Au(en)Cl2]
+ + 3e−→
Au(0)+en+2Cl– [33]) was shifted toward more negative po-
tential of 0.05 V (peak II, Fig. 2a and Table 2). The anodic
peak II′ at 0.80 V, detected in the cyclic voltammogram,
corresponds to the oxidation of Au(0) to [AuCl4]
− [31, 33,
37], while the second cathodic peak III at 0.40 V is assigned to
the reduction of the already formed [AuCl4]
− complex to
Au(0) in accordance with the previously reported data [31,
33, 37] (Table 2). The presence of metallic gold on the
electrode surface also confirmed the reduction of Au(III)
complex to Au(0). In accordance to the previous results
[37–39], it was not possible to detect [AuCl2]
− complex, due
to its disproportionation to [AuCl4]
− and Au(0) in aqueous
solution:
3 AuCl2½ –↔2Au 0ð Þ þ AuCl4½ – þ 2Cl– ð1Þ
The disproportionation of [AuCl2]
− complex was found to
be slow in the early stage, but then rapidly increased to the
values that remained approximately constant with further
reaction progress (logK =7.4 at 25 °C) [39, 40]. When the
reaction was followed during time, the current responses for
the cathodic peaks II and III increased (Fig. 2b), which is in
accordance with the progress of the reduction of Au(III)
species to Au(0).
In addition, the reaction of [Au(en)Cl2]
+ with Gly-Met has
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Fig. 1 Schematic presentation of the oxidation of methionine residue in
Gly-Met dipeptide in the presence of [Au(en)Cl2]
+ complex and parts of
the proton NMR spectra for the reactants and products formed after 24 h.
The dipeptide and gold(III) complex were mixed in 1:1 molar ratio in
0.50 M KCl at pH 2.00 and 25 °C
Table 1 1H NMR characterization of [Au(en)Cl2]
+, Gly-Met and prod-
ucts of their reaction in 1:1 molar ratio
Reactants/products 1H NMR chemical shifts (δ , ppm)a
[Au(en)Cl2]
+ 3.27 (s , enCH2)
Gly-Met 2.11 (s , –SCH3), 2.18 (m , MetβCH2)
2.58 (m , MetγCH2), 3.87 (s , GlyCH2)
4.32 (t , MetαCH2)
free en 3.38 (s , enCH2)
Gly-Met sulfoxide 2.71 (s , –SCH3), 2.40 (m , MetβCH2)
3.00 (m , MetγCH2), 3.87 (s , GlyCH2)
4.32 (t , MetαCH2)
All spectra were recorded at pH 2.00 in 0.50 M KCl in D2O with TSP as
the internal standard
aNo influence of the pH (2.00–5.00) and KCl concentration (0.01–0.50 M)
was observed on the chemical shifts (s = singlet; t = triplet; m = multiplet)
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time intervals. When an equimolar amount of the dipeptide was
added to a solution of the [Au(en)Cl2]
+ complex, the absorbance
of maximum at λ=305 nm decreased during time, indicating a
decrease of the concentration of Au(III) species due to its reduc-
tion. As an illustration of this finding, the UV–vis spectra of the
investigated reaction in 0.50 M KCl at pH 2.00 as a function of
time are presented in Fig. 3. The reaction between [Au(en)Cl2]
+
and Gly-Met has been studied in an excess of the dipeptide. The
gold(III) complex and Gly-Met were mixed in 1:2 and 1:3 molar
ratios, respectively, and the UV–vis spectra were recorded at
appropriate time intervals. As it was shown in the inserted chart
(Fig. 3), the absorbance ofmaximum at λ=305 rapidly decreased
with increase of the dipeptide concentration, which is in accor-
dance with the previously reported results for the reaction be-
tween this dipeptide and [AuCl4]
− complex [31]. However, the
influence of an excess of [Au(en)Cl2]
+ complex on the peptide
oxidation could not be observed due to the fact that an initially
formed [AuCl2]
− undergoes disproportionation to [AuCl4]
− and
Au(0) (see Eq. 1).
The influence of the pH and chloride concentration on the rate
of release of ethylenediamine from [Au(en)Cl2]
+
in the reaction with Gly-Met
The release of ethylenediamine from [Au(en)Cl2]
+ in the reaction
with Gly-Met is an important step in the formation of Gly-Met
sulfoxide. The rate of this process has been investigated in the
presence of different chloride concentration (0.01–0.50 M KCl)
in the pH range 2.00–5.00 (Table 3). The first-order rate constants
were calculated from the integral values of themethylene protons
for the free and coordinated ligand (Fig. 1). As it can be seen in
Table 3, the observed rate constants markedly decrease with
increasing the pH. Thus, the release of en ligand in 0.50 M
KCl at pH 2.00 (k=(36.23±1.07)·10−6 s−1) is approximately 15
times faster in comparison to the same process at pH 5.00
(k=(2.35±0.07)·10−6 s−1). This difference can be attributed to
the fact that higher H+ concentration favors the release of en
ligand by protonation of its amino groups [41]. Furthermore, it is
obvious that the increase of Cl− concentration from 0.01 M
(k = (1.29 ± 0.18)·10−6 s−1) to 0.50 M (k = (36.23 ±
1.07)·10−6 s−1) accelerates the detachment of en ligand from
Au(III) ion (Table 3). As a consequence of this detachment, the
percentage of the Gly-Met sulfoxide increased with decreasing
the pH (Fig. 4a) and increasing Cl− concentration (Fig. 4b). The
amount of sulfoxide obtained after 2 h of the reaction in 0.50 M


































Fig. 2 Cyclic voltammograms of a [Au(en)Cl2]
+ and its reaction with an
equimolar amount of Gly-Met and b during progress of the reaction,
recorded at a GC electrode in 0.50 M KCl at pH 2.00 and 25 °C
Table 2 Positions and redox reactions associated with observed cathodic and anodic peaks in cyclic voltammograms of [Au(en)Cl2]
+ complex and its
reaction with an equimolar amount of Gly-Met recorded at a GC electrode in 0.50 M KCl at pH 2.00 and 25 °C
Gold(III) complex/reaction Process Peak E (V) Redox reaction Reference
[Au(en)Cl2]
+ Reduction I 0.15 [Au(en)Cl2]
+ + 3e−→Au(0)+en+2Cl− [33]
Oxidation I′ 0.90 Au(0)+4Cl−→[AuCl4]
−+3e− [31, 33, 37]
[Au(en)Cl2]
+ + Gly-Met Reduction II 0.05 [Au(en)Cl(Gly-Met-S)]2+ + 3e−→Au(0)+Gly-Met
sulfoxide+en+Cl−
[This work]
Reduction III 0.40 [AuCl4]
−+3e−→Au(0)+4Cl− [31, 33, 37]
Oxidation II′ 0.80 Au(0)+4Cl−→[AuCl4]
−+3e− [31, 33, 37]
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at pH 5.00 (14%) under the sameCl− concentration.On the other
hand, the increase of Cl− concentration from 0.01 to 0.50MKCl
results in the increase of the sulfoxide concentration from 15 to
52 %, respectively (at pH 2.00 after 2 h of progress of the
reaction). Finally, it can be stated that the increase of the concen-
tration of H+ and Cl− ions accelerates the investigated redox
process.




In order to investigate the influence of chelated ethylenediamine
ligand on the redox potential of [Au(en)Cl2]
+, we compared the
rate constant for the oxidation of methionine residue in Gly-Met
in the presence of [Au(en)Cl2]
+ complex with that previously
reported for [AuCl4]
− under the same experimental conditions
[31]. The [Au(en)Cl2]
+ and Gly-Met were dissolved in 0.01 M
DCl at pH 2.00 and 25 °C, and then mixed in 1:1 molar ratio. It
was found that the oxidation of methionine residue with
[Au(en)Cl2]
+ (k2=(1.74±0.05)·10
−3 M−1 s−1) was about 200
t imes slower that with [AuCl4]
− (k 2 = (363.00 ±
74.00)·10−3 M−1 s−1) [31]. Large difference in the oxidation
rates between these two complexes undoubtedly confirms that
the bidentate coordinated en ligand stabilizes Au(III) ion, which
results in slower peptide oxidation in the presence of
[Au(en)Cl2]
+ in comparison with [AuCl4]
− complex.
Conclusions
From the present investigation of the reaction of [Au(en)Cl2]
+
complex with Gly-Met the following conclusions can be
drawn. The final product in this reaction is Gly-Met sulfoxide
resulted from the oxidation of methionine side chain induced
by Au(III) ion. The formation of this product proceeds in two




















Fig. 3 The UV–vis spectra for the reaction of [Au(en)Cl2]
+ with an
equimolar amount of Gly-Met in 0.50 M KCl at pH 2.00 and 25 °C as
a function of time: a 1 min, b 20 min, c 1 h, d 3 h, e 24 h. The inserted
chart shows dependence of the absorbance in relation to the increasing
concentration of Gly-Met
Table 3 The influence of the pH and chloride concentration on the first-
order rate constants (k 10−6 s−1) for the release of en ligand from
[Au(en)Cl2]
+ in the redox reaction with an equimolar amount of Gly-
Met at 25 °C
pHa k 10−6 s−1 [Cl−] (mol/dm3)b k 10−6 s−1
2.00 36.23±1.07 0.01 1.29±0.18
3.00 12.84±0.51 0.05 4.88±0.10
4.00 7.80±0.33 0.10 9.58±0.52
5.00 2.35±0.07 0.50 36.23±1.07
















































Fig. 4 Time dependence of the amount of Gly-Met sulfoxide (%) formed
in the reaction between [Au(en)Cl2]
+ and Gly-Met (1:1 molar ratio) on a
pH (2.00–5.00) and b concentration of KCl (0.01–0.50 M)
38 Gold Bull (2014) 47:33–40
sulfur atom and detachment of ethylenediamine ligand from
the Au(III) complex. The investigation shows that the
[AuCl2]
− complex, formed in the reaction with an equimolar
amounts of reactants, has a strong tendency to disproportion-
ate, forming [AuCl4]
− and metallic gold, Au(0). The oxidation
of methionine residue in Gly-Met is strongly dependent on the
pH and chloride concentration. In comparison with [AuCl4]
−,
the oxidation of Gly-Met dipeptide in the presence of
[Au(en)Cl2]
+ complex is 200 times slower. This finding leads
to the conclusion that the oxidation of thioether sulfur atom in
methionine-containing peptides can be inhibited by chelation
of Au(III) ion with polydentate ligands containing nitrogen
donor atoms. Considering this, our latest results could have an
impact on designing new gold(III) complexes as potential
antitumor agents with lower toxic side effects.
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